Rheumatology Advance Access originally published online on January 25, 2006
Rheumatology 2006 45(5):636-637; doi:10.1093/rheumatology/kel020
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2006. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
LETTER TO THE EDITOR |
Treatment of rheumatoid arthritis with ornidazole. A randomized, double-blind, placebo-controlled study
Department of Physical Medicine and Rehabilitation Nazilli State Hospital, Nazilli, Aydin and 1 Department of Physical Medicine and Rehabilitation, University of Trakya School of Medicine, Edirne, Turkey
Correspondence to: M. Ogrendik, Altintas mah. Kocacami cad., Erten Kocabay Apt., No. 2, Kat:6, 09800, Nazilli-Aydin, Turkey. E-mail: mogrendik@hotmail.com
| The first 10% of the full text of this article appears below. |
SIR, In many previous studies, rheumatoid arthritis (RA) has been found at high frequencies in individuals with periodontitis, and RA resembles periodontitis in many pathological aspects [1, 2]. HLA-DR4 tissue antigens are found at high frequencies both in patients with periodontitis and in those with RA. HLA-DR4 tissue antigens and their subtypes are directly associated with each disease [3, 4].
High levels of oral anaerobic bacterial antibodies and heat-shock proteins have been found in the